Visitor Monitoring Drug Details: RAZADYNE ER
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Drug Details

Drug Name: RAZADYNE ER
FDA Application No: (NDA) 021615
Active Ingredient(s): GALANTAMINE HYDROBROMIDE
Company: JANSSEN
Original Approval or Tentative Approval Date: December 22, 2004
Chemical Type: 3 New dosage form
Review Classification: S Standard review drug
 
There are no Therapeutic Equivalents Label Information
Approval History, Letters, Reviews and Related Documents
 
You can see the products in the same application. The table can be sorted by clicking the header columns.
 
Drug NameSort imageActive IngredientsStrengthDosage Form/RouteMarketing StatusRLDTE Code
RAZADYNE ER GALANTAMINE HYDROBROMIDEEQ 8MG BASECAPSULE, EXTENDED RELEASE; ORAL Prescription Yes None
RAZADYNE ER GALANTAMINE HYDROBROMIDEEQ 16MG BASECAPSULE, EXTENDED RELEASE; ORAL Prescription No None
RAZADYNE ER GALANTAMINE HYDROBROMIDEEQ 24MG BASECAPSULE, EXTENDED RELEASE; ORAL Prescription No None


Comments for RAZADYNE ER
 
 
Name: *
 
Email: *
 
Text:
(HTML OK)
 
Enter the code from the picture: *
(click here to load another image)
 
 
  
There are no comments.
©2019 Drugs That Causes a False Positive on a Drug Test